Search

Your search keyword '"Sarcolemma immunology"' showing total 130 results

Search Constraints

Start Over You searched for: Descriptor "Sarcolemma immunology" Remove constraint Descriptor: "Sarcolemma immunology"
130 results on '"Sarcolemma immunology"'

Search Results

1. Autoantibodies targeting TRIM72 compromise membrane repair and contribute to inflammatory myopathy.

2. Sarcolemmal Complement Membrane Attack Complex Deposits During Acute Rejection of Myofibers in Nonhuman Primates.

3. A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients.

4. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.

5. Necrosis, sarcolemmal damage and apoptotic events in myofibers rejected by CD8+ lymphocytes: Observations in nonhuman primates.

6. Immunohistochemical analysis of MCT1 and CD147 in equine skeletal muscle fibres.

7. Immunoadsorption as treatment option in dilated cardiomyopathy.

8. Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls.

9. Sarcolemma-specific autoantibodies in canine inflammatory myopathy.

10. Antigen-specific effects of autoantibodies against sarcolemmal Na-K-ATPase pump in immunized cardiomyopathic rabbits.

11. Immune-mediated rippling muscle disease.

12. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

13. Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy.

14. Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.

15. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells.

16. Amyloid myopathy: evidence for mechanical injury to the sarcolemma.

17. A possible role for complement in the pathogenesis of chronic chagasic cardiomyopathy.

18. The beta1 integrin subunit is not a specific component of the costamere domain in human myocardial cells.

19. An immunological approach to postpericardiotomy syndrome occurrence and its relation with autoimmunity.

20. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].

21. Immune responses in endocarditis.

22. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.

23. Human leukocyte antigen class I in polymyositis: leukocyte infiltrates, regeneration, and impulse block.

24. Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin.

25. [The activating effect of antisarcolemmal antibodies on the contractile reactions of the papillary muscles of the rat heart].

26. [The membrane mechanism of the development of tonic stress in the heart muscle of rats under the action of antimembrane antibodies].

27. Identification of a 65 kDa endothelin receptor in bovine cardiac sarcolemmal vesicles.

28. A 28 kDa sarcolemmal antigen in kidney principal cell basolateral membranes: relationship to orthogonal arrays and MIP26.

29. Trypanosoma cruzi: recognition of a 43-kDa muscle glycoprotein by autoantibodies present during murine infection.

30. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.

31. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis.

32. Mimicry of heart cell surface epitopes in primary anti-Trypanosoma cruzi Lyt 2+ T lymphocytes.

33. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance.

34. Cardiocytolytic antimyolemmal antibodies in dilated cardiomyopathy following presentation: observations in 7 patients.

35. Serum antibody responses to Streptococcus mutans antigens in humans systemically infected with oral streptococci.

36. Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis.

37. Anticardiac antibodies in hypertrophic cardiomyopathy as a marker of severity.

38. Human heart sarcolemmal sheath antibodies in children with non-suppurative sequelae of group A streptococcal infections: a follow up study.

39. Genetic control of Coxsackievirus B3-induced heart-specific autoantibodies associated with chronic myocarditis.

40. Modulation of the activity of the transverse tubule Mg(2+)-ATPase from frog skeletal muscle by a monoclonal antibody in vitro.

41. Prognostic determinants in conventionally treated myocarditis and perimyocarditis--focus on antimyolemmal antibodies.

42. Impaired myocyte function in vitro incubated with sera from patients with myocarditis.

43. Two major antigens of heart sarcolemma are Ca2(+)-binding glycoproteins that copurify with the dihydropyridine receptor.

44. Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies?

45. Immunological cross-reactivity between Streptococcus mutans and human heart tissue examined by cross-immunization experiments.

46. Immunocytochemical study of dystrophin at the myotendinous junction.

47. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.

48. Immune reactions in infective endocarditis. I. Clinical data and diagnostic relevance of antimyocardial antibodies.

49. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.

50. Murine monoclonal antibodies reactive with human heart and group A streptococcal membrane antigens.

Catalog

Books, media, physical & digital resources